Bio-piracy — Intellectual Property Rights II Notes

Bio-piracy

Three names win this short note every time: turmeric, neem and Basmati. Each was an Indian resource that someone abroad tried to patent as their own “invention”. Each fight India eventually won. Together they are the textbook definition of bio-piracy in action.

What bio-piracy is

Bio-piracy is the unauthorised access to, and commercial exploitation of, biological resources or associated traditional knowledge, without permission and without fair benefit-sharing — usually by patenting them abroad. It is the very mischief the BD Act 2002 was written to stop.

The classic examples:

• Turmeric (USPTO, 1997) — a US patent on turmeric’s wound-healing use was revoked after India produced ancient texts; the use was old and public.
• Neem (EPO, 2000/2005) — a European patent on neem’s anti-fungal use was revoked; it was traditional knowledge.
• Basmati (RiceTec, US, 1997–2001) — a US company’s “Basmati” rice-line patent was largely struck down after India’s challenge, protecting the name and germplasm.

How the BD Act counters bio-piracy

• Access regulation — ss.3, 6, 7: no access or foreign patenting of Indian bio-resources without approval.
• s.18(4) — the NBA takes measures to oppose grant of IP rights abroad on Indian resources/TK.
• Documentation — the TKDL and People’s Biodiversity Registers put the knowledge on record as prior art, so foreign patent offices refuse wrongful claims.
• Benefit-sharing — s.21 ensures value flows back to the source communities.

In Simple Terms: Bio-piracy = taking India’s biological wealth or know-how and monopolising it abroad, giving nothing back. The Act fights it with access approvals (ss.3, 6), the NBA’s duty to oppose foreign patents (s.18(4)), documentation (TKDL/PBR), and benefit-sharing (s.21).

🧩 WORKED EXAMPLE — the neem patent

Facts. A foreign entity patents the fungicidal use of neem, long used by Indian farmers.

Rule. A use already known to a community is not novel; documented TK is prior art, and the NBA may oppose the patent (s.18(4)).

Apply. India showed neem’s fungicidal use was ancient and public; the “invention” lacked novelty.

Conclusion. The patent was revoked — a textbook defeat of bio-piracy.

flowchart TD
    ROOT["Bio-piracy"]:::root
    ROOT --> A["Examples: turmeric, neem, Basmati"]:::leaf
    ROOT --> B["Counter: access control (s.3/6/7)"]:::leaf
    ROOT --> C["Counter: oppose foreign patents (s.18(4))"]:::leaf
    ROOT --> D["Counter: TKDL / PBR documentation + benefit-sharing"]:::leaf
    classDef root fill:#FFF8DC,stroke:#000,stroke-width:1px,color:#000;
    classDef leaf fill:#E6F3FF,stroke:#1E3A8A,color:#000;
    linkStyle default stroke:#888,stroke-width:1px;

Case Laws

• Turmeric patent case (USPTO, 1997) — patent revoked; known Indian TK is not novel.
• Neem patent case (EPO, 2000/2005) — European patent revoked on the same principle.

Back to Top

📄 Full notes + Question Bank (₹199) — every topic in depth, model answers to all past KSLU questions, in one printable PDF. Get the bundle · 10 Solved Problems · All Intellectual Property Rights II topics